Characterization of the pVHL Interactome in Human Testis Using High-Throughput Library Screening.
PMID:35205757
The Role of VHL in the Development of von Hippel-Lindau Disease and Erythrocytosis.
PMID:35205407
Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service.
PMID:35184155
Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype-phenotype correlation and gene therapy perspective.
PMID:34923986
Central Nervous System Hemangioblastoma in a Pediatric Patient Associated With Von Hippel-Lindau Disease: A Case Report and Literature Review.
PMID:34109129
Algorithmic assessment of missense mutation severity in the Von-Hippel Lindau protein.
PMID:33151962
The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel-Lindau tumor suppressor.
PMID:32985545
The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer.
PMID:32603638
Assessing predictors for new post translational modification sites: A case study on hydroxylation.
PMID:32569263
Von Hippel-Lindau: implications in development and disease-response.
PMID:32175434
von Hippel-Lindau Syndrome: Genetic Study of Case With a Rare Pathogenic Variant With Optic Nerve Hemangioblastoma, a Rare Phenotypic Expression.
PMID:32117777
Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors.
PMID:30943211
von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
PMID:30890701
Arginine refolds, stabilizes, and restores function of mutant pVHL proteins in animal model of the VHL cancer syndrome.
PMID:30194449
Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI.
PMID:28440912
Novel interactions of the von Hippel-Lindau (pVHL) tumor suppressor with the CDKN1 family of cell cycle inhibitors.
PMID:28425505